The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages

...

21 March, 2023

What is meant by Off-label

...

08 March, 2023

Negotiating a Round in the health sector (Part 2) The roadshow and the negotiation of the deal

...

23 February, 2023

DIGI-HEART: The digital cardiac mapping tool based on Digital Twins

...

01 February, 2023

GENESIS Biomed sponsors ITEMAS 2022 Annual Conference Day

...

19 January, 2023

GENESIS Biomed continues growing and adding value in biomedical sector

...

15 December, 2022

The Investor Deck, the startup’s business card

...

23 November, 2022

Value-based medicine and Risk Sharing Agreement

...

09 November, 2022

Interview Xavier Luria. Vice president at Veristat – regulatory consultancy firm

...

25 October, 2022

Diabetic patients in rural areas will be able to be diagnosed with diabetic retinopathy in the early stages of the disease thanks to a mobile system

...

06 October, 2022